Fisher Danina
SEC insider (Form 3/4/5 filer). CIK 0002144035. Director at Hepion Pharmaceuticals, Inc. (HEPA). 2 reported Form 4/5 transactions since Sep 2024; latest on Sep 29, 2026. Located in RED BANK,, NJ.
Companies Fisher Danina has filed insider reports for
- Hepion Pharmaceuticals, Inc. (HEPA): Director
Fisher Danina
CIK: 0002144035
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HEPA
Hepion Pharmaceuticals, Inc.
Director